丰原药业(000153.SZ)发布前三季度业绩，归母净利润1亿元，同比下降31.92%

Core Viewpoint - Fengyuan Pharmaceutical (000153.SZ) reported a decline in both revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 3.125 billion yuan, representing a year-on-year decrease of 4.18% [1] - The net profit attributable to shareholders of the listed company was 100 million yuan, down 31.92% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 74.9151 million yuan, reflecting a year-on-year decline of 36.39% [1]